Mirus Bio's Acquisition

Mirus Bio was acquired by Roche Holding on July 22, 2008.

Mirus Bio operates in the fields of RNA interference and gene therapy, based upon its expertise in nucleic acid chemistry and delivery. The company's Dynamic PolyConjugates technology is being refined…

Articles about Mirus Bio's Acquisition: